Cargando…

Docking cholesterol to integral membrane proteins with Rosetta

Lipid molecules such as cholesterol interact with the surface of integral membrane proteins (IMP) in a mode different from drug-like molecules in a protein binding pocket. These differences are due to the lipid molecule’s shape, the membrane’s hydrophobic environment, and the lipid’s orientation in...

Descripción completa

Detalles Bibliográficos
Autores principales: Marlow, Brennica, Kuenze, Georg, Meiler, Jens, Koehler Leman, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042369/
https://www.ncbi.nlm.nih.gov/pubmed/36972273
http://dx.doi.org/10.1371/journal.pcbi.1010947
_version_ 1784912919513792512
author Marlow, Brennica
Kuenze, Georg
Meiler, Jens
Koehler Leman, Julia
author_facet Marlow, Brennica
Kuenze, Georg
Meiler, Jens
Koehler Leman, Julia
author_sort Marlow, Brennica
collection PubMed
description Lipid molecules such as cholesterol interact with the surface of integral membrane proteins (IMP) in a mode different from drug-like molecules in a protein binding pocket. These differences are due to the lipid molecule’s shape, the membrane’s hydrophobic environment, and the lipid’s orientation in the membrane. We can use the recent increase in experimental structures in complex with cholesterol to understand protein-cholesterol interactions. We developed the RosettaCholesterol protocol consisting of (1) a prediction phase using an energy grid to sample and score native-like binding poses and (2) a specificity filter to calculate the likelihood that a cholesterol interaction site may be specific. We used a multi-pronged benchmark (self-dock, flip-dock, cross-dock, and global-dock) of protein-cholesterol complexes to validate our method. RosettaCholesterol improved sampling and scoring of native poses over the standard RosettaLigand baseline method in 91% of cases and performs better regardless of benchmark complexity. On the β2AR, our method found one likely-specific site, which is described in the literature. The RosettaCholesterol protocol quantifies cholesterol binding site specificity. Our approach provides a starting point for high-throughput modeling and prediction of cholesterol binding sites for further experimental validation.
format Online
Article
Text
id pubmed-10042369
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-100423692023-03-28 Docking cholesterol to integral membrane proteins with Rosetta Marlow, Brennica Kuenze, Georg Meiler, Jens Koehler Leman, Julia PLoS Comput Biol Research Article Lipid molecules such as cholesterol interact with the surface of integral membrane proteins (IMP) in a mode different from drug-like molecules in a protein binding pocket. These differences are due to the lipid molecule’s shape, the membrane’s hydrophobic environment, and the lipid’s orientation in the membrane. We can use the recent increase in experimental structures in complex with cholesterol to understand protein-cholesterol interactions. We developed the RosettaCholesterol protocol consisting of (1) a prediction phase using an energy grid to sample and score native-like binding poses and (2) a specificity filter to calculate the likelihood that a cholesterol interaction site may be specific. We used a multi-pronged benchmark (self-dock, flip-dock, cross-dock, and global-dock) of protein-cholesterol complexes to validate our method. RosettaCholesterol improved sampling and scoring of native poses over the standard RosettaLigand baseline method in 91% of cases and performs better regardless of benchmark complexity. On the β2AR, our method found one likely-specific site, which is described in the literature. The RosettaCholesterol protocol quantifies cholesterol binding site specificity. Our approach provides a starting point for high-throughput modeling and prediction of cholesterol binding sites for further experimental validation. Public Library of Science 2023-03-27 /pmc/articles/PMC10042369/ /pubmed/36972273 http://dx.doi.org/10.1371/journal.pcbi.1010947 Text en © 2023 Marlow et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Marlow, Brennica
Kuenze, Georg
Meiler, Jens
Koehler Leman, Julia
Docking cholesterol to integral membrane proteins with Rosetta
title Docking cholesterol to integral membrane proteins with Rosetta
title_full Docking cholesterol to integral membrane proteins with Rosetta
title_fullStr Docking cholesterol to integral membrane proteins with Rosetta
title_full_unstemmed Docking cholesterol to integral membrane proteins with Rosetta
title_short Docking cholesterol to integral membrane proteins with Rosetta
title_sort docking cholesterol to integral membrane proteins with rosetta
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042369/
https://www.ncbi.nlm.nih.gov/pubmed/36972273
http://dx.doi.org/10.1371/journal.pcbi.1010947
work_keys_str_mv AT marlowbrennica dockingcholesteroltointegralmembraneproteinswithrosetta
AT kuenzegeorg dockingcholesteroltointegralmembraneproteinswithrosetta
AT meilerjens dockingcholesteroltointegralmembraneproteinswithrosetta
AT koehlerlemanjulia dockingcholesteroltointegralmembraneproteinswithrosetta